Goldman Sachs
ASTX

Goldman Sachs’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Goldman Sachs’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-584,741
Closed -$4.96M – 7014
2013
Q3 		$4.96M Buy
584,741
+90,726
+18% +$574K ﹤0.01% 2925
2013
Q2 		$2.03M Buy
+494,015
New +$2.66M ﹤0.01% 3718

Goldman Sachs's ASTX Position: Q4 2013 in Review

Goldman Sachs sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 584,741 shares — an estimated $4.96M sold.

Goldman Sachs first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $4.96M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Goldman Sachs reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Goldman Sachs sold 584,741 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $4.96M.
  • Goldman Sachs first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Goldman Sachs's ASTEX PHARMACEUTICALS, INC COM position peaked at $4.96M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Goldman Sachs's 13F filing for Q4 2013, filed 14 Feb 2014.